Laserscope and Exim sign marketing agreement:
This article was originally published in Clinica
Executive Summary
Lasercope, which manufactures medical lasers and surgical support products, granted Exim International marketing rights to sell its products in the People's Republic of China, Hong Kong and Vietnam. Exim specialises in trading with China, and estimates that the external investment in China's healthcare industry is about Yuan 85,000 million ($11 000 million), of which the medical device industry's investment is Yuan 2,000 million. Laserscope's products include KTP/532, CO(2), Nd:YAG, Er:YAG and ruby medical lasers.